TSH Biopharm Corporation Limited announced the change of financial officer. Name, title, and resume of the previous position holder: Financial officer: Chen-Ju Kan/Senior Manager of the Accounting. Department.

Acting spokesperson: Chao-Jen Liao/Division Director of Business Development Division. Name, title, and resume of the new position holder: Financial officer and acting spokesperson: Shu-Ping Huang/Manager of the Administrative Department. Reason for the change: Functions of organization and position adjustment.

Effective date: January 1, 2024. Any other matters that need to be specified: The newly appointed financial officer and acting spokesperson will take office on January 1, 2024.